Navigation Links
Adult Smoking Rate Continues Downward Trend
Date:8/19/2007

People of lower income and education still smoke more and are less likely

to quit

OLYMPIA, Wash., Aug. 1 /PRNewswire-USNewswire/ -- A new survey by the Washington State Department of Health shows the number of adult smokers in the state is continuing to drop. Since the department began its Tobacco Prevention and Control Program in 2000, adult smoking has gone from 22.4 percent to a new low of 17 percent. Washington continues to have the fifth lowest smoking rate in the nation.

The most recent numbers from the Behavioral Risk Factor Surveillance System survey show a decline from a 17.6 percent smoking rate in 2005 to 17 percent in 2006. Although a relatively small drop, the data confirm a continued trend of fewer people smoking in our state. The overall drop in smoking since 2000 translates to about 235,000 fewer smokers in the state, and $2.1 billion saved in future health care costs for Washington.

"It is clear that Washington is making strides in reducing smoking and I am pleased with the progress; yet we need to do more to help those who are having problems quitting for good," said Governor Chris Gregoire.

The latest research shows that people with low income (less than $25,000/year) and less education (high school diploma or less) smoke at higher rates than the general population and are less likely to quit successfully. Smoking among these groups has not dropped significantly in recent years.

"Tobacco prevention and control is a priority for our state, and overall it is paying off with fewer smokers," said Secretary of Health Mary Selecky. "At the same time, I'm concerned about the higher smoking rates for some groups. We continue to look for new and creative ways to reach people with low income, lower levels of education, and others who are more likely to smoke."

Smoking rates are higher among low income adults at 30 percent; the rate is 27 percent among people with less education. Co
'/>"/>

SOURCE Washington State Department of Health

Copyright©2007 PR Newswire.

Page: 1 2

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
3. Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia
4. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
5. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
6. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
7. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
8. Major Manufacturer of Unapproved and Adulterated Drugs
9. FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications
10. New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
11. Eighty-one Percent of U.S. Adults say that Birth Control Pills and Procedures Should Be Covered by Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...tatistical significance , , ISELIN, N.J., N...ion (Nasdaq: PARS ) today announced results from...ulsion (NE) drug delivery technology formulated wi...lti-center, randomized, double-blinded, placebo-co...f the Company,s 3% Diclofenac Diethanolamine NanoE...
(Date:11/18/2008)...stCall/ -- NeuroDiscovery Ltd (ASX:,NDL), a speci...pment Company,and Sosei Group Corporation ("Sose...onal biopharmaceutical company, today announce tha...e-clinical efficacy data for NSL-043/SD118.,This ...uropathic pain and has,successfully completed Pha...
(Date:11/18/2008)...diagnosed, elderly AML patients , , PRINCET...uticals today announced that the first patient has...dy of CPX-351 (Cytarabine:Daunorubicin) Liposome I...eloid leukemia (AML). , , The first patient...dical College of Cornell University and New York ...
(Date:11/12/2008)...D. Watson, Marilyn & James Simons and,Sherry Lansi...ov. 12 J. Craig Venter,...er Institute (JCVI), was,awarded the Double Helix ...,November 6th at a gala event in New York City., ...ith Dr. James D.,Watson for making each of their i...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2Pulmo BioTech Announces Appointment of Chief Financial Officer 5069 1Pulmo BioTech Announces Appointment of Chief Financial Officer 5069 2Pulmo BioTech Announces Appointment of Chief Financial Officer 5069 3Got Fat 3F 3A Plastic Surgeons Review Fat Melting and Fat Grafting Procedures 1960 1Got Fat 3F 3A Plastic Surgeons Review Fat Melting and Fat Grafting Procedures 1960 2Got Fat 3F 3A Plastic Surgeons Review Fat Melting and Fat Grafting Procedures 1960 3Environmental fate of nanoparticles depends on properties of water carrying them 3161 1Environmental fate of nanoparticles depends on properties of water carrying them 3161 2Environmental fate of nanoparticles depends on properties of water carrying them 3161 3Thermage a Leading Aesthetic Medical Device Company Announces First Time Exhibitor Status at ACOG Meeting 18263 1Thermage a Leading Aesthetic Medical Device Company Announces First Time Exhibitor Status at ACOG Meeting 18263 2Thermage a Leading Aesthetic Medical Device Company Announces First Time Exhibitor Status at ACOG Meeting 18263 3
(Date:11/21/2008)...nd schools need to work together to stop abusive b... (HealthDay News) -- Behavior that was once dismis...ying. , And as mounting research shows the nega...tal-health professionals, schools, parents and eve...ombat this threatening behavior. , "Bullying s...
(Date:11/21/2008)...1, 2008)The University of Texas Health Science Cen... Excellence in Aging Studies (TEXAS), to promote g...gious $2 million award from the Donald W. Reynolds... "This will allow us to teach geriatric medicine p... student to practicing physicians. With the reach ...
(Date:11/21/2008)...Nov. 21 The Providence S...ced that Craig A. Norris, the Company,s,Chief Ope...s Board of,Directors. Mr. Norris, appointment fi...n of Steven I. Geringer and returns the board to s...mittee of the Board. , Mr. Norris, age 41, ...
(Date:11/21/2008)...anzel proved effective against Lennox-Gastaut synd...) -- A new drug called Banzel (rufinamide) has bee...re form of epilepsy called Lennox-Gastaut syndrome...Friday. , The approval was based on results of ... ages 4 to 30. Compared to patients who took a pla...
Breaking Medicine News(10 mins):Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:FDA Approves New Drug for Severe Epilepsy 2
...has been tons of information circulating around do...ign has asked donor-conceived parents to speak to ...ities were flooded with inquiries in this regard. ...lls and emails from parents of donor-conceived chi...
...bad-based Dishman Pharmaceuticals and Chemicals Lt...rvices business of US-based Solutia Inc for 74.5 m...ement for purchasing 100 per cent stake in CarboGe... pharmaceutical services division, Dishman said in...
...ng a decrease in the child mortality rate from 86 ...lans to bring it down further by earmarking Rs 2.6...ildren. // The benefits reaching women and childr... to all and the government will spend Rs 2.63 cror...
...sing serious concern over growing problems due to ...Social Justice and Empowerment Meira Kumar today s...tems in the region to check it. There is a need to...ng and reporting systems for all seven-sister stat...
Other Medicine News:
...The ACCU-Beam® line of Surgical Microscope Acc...litters, objective lenses, fiber optic cables, and...e Dual Adaptor allows the surgeon to document proc...eo or 35mm photography. Many different types of ad...
...The ACCU-Beam® line of Surgical Microscope Acc...litters, objective lenses, fiber optic cables, and...ersal Microsurgical Video Adaptor (US pat. no. 5,2...both single-chip and 3CCD cameras on the same adap...
...ALLEGRO Topolyzer and T-CAT have been optimized to...rection and to interact in perfect synchronization...ll necessary treatment and patient parameters are ...GRETTO WAVE laser systems via diskette, mini CD or...
...The WaveScan WaveFront System is an ophthalmic dia...ror and wavefront aberrations of the human eye usi...ents can be used to determine regular (sphero-cyli...rrations) that cause decreased or blurry vision in...
Medicine Products: